Clinical utility of AQP4-IgG titers and measures of complement-mediated cell killing in NMOSD.
Jitprapaikulsan J, Fryer JP, Majed M, Smith CY, Jenkins SM, Cabre P, Hinson SR, Weinshenker BG, Mandrekar J, Chen JJ, Lucchinetti CF, Jiao Y, Segan J, Schmeling JE, Mills J, Flanagan EP, McKeon A, Pittock SJ.
Jitprapaikulsan J, et al. Among authors: schmeling je.
Neurol Neuroimmunol Neuroinflamm. 2020 May 28;7(4):e727. doi: 10.1212/NXI.0000000000000727. Print 2020 Jul.
Neurol Neuroimmunol Neuroinflamm. 2020.
PMID: 35413004
Free PMC article.